ISPOR - The use of a Dabigatran-Specific Reversal Agent- Budget Impact Analysis from the Hospital Perspective and the French Public Payer Perspective

Full Text

The use of a Dabigatran-Specific Reversal Agent- Budget Impact Analysis from the Hospital Perspective and the French Public Payer Perspective

Abstract

Authors

N Jamet S Bourguignon K Le Lay

Back to Volume 19, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now